Access cutting-edge primary immunodeficiencies treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access primary immunodeficiencies specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary immunodeficiencies treatment provided free
Background: Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers think this may help people with immune system problems. Objective: To see if allogeneic blood or bone marrow transplant is safe and effective in treating people with primary immunodeficiencies. Eligibility: Donors: Healthy people ages 4 or older Recipients: People ages 4-75 with a primary immunodeficiency that may be treated with all
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this primary immunodeficiencies clinical trial in Minneapolis, MN
If you're searching for primary immunodeficiencies treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary immunodeficiencies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.